Enfermedades Infecciosas

Vena, A; Bouza, E; Bassetti, M; Menichetti, F; Merelli, M; Grau, S; Fortun, J; Sanchez, MI; Aguado, JM; Merino, P; Bonache, F; Munoz, P.

Comparison of the Safety and Tolerance Profile of Micafungin with that of Other Echinocandins and Azoles in Patients with Pre-existing Child-Pugh B or C Liver Disease: A Case-Control Retrospective Study

Infectious Diseases and Therapy. 2020; 9(1): 151-163 Nº de citas: 5 [doi:10.1007/s40121-020-00282-w]

Vena, A; Munoz, P; Mateos, M; Guinea, J; Galar, A; Pea, F; Alvarez-Uria, A; Escribano, P; Bouza, E.

Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?

Infectious Diseases and Therapy. 2020; 9(1): 137-149 Nº de citas: 41 [doi:10.1007/s40121-020-00280-y]

Aguilera-Alonso, D; Escosa-Garcia, L; Saavedra-Lozano, J; Cercenado, E; Baquero-Artigao, F.

Carbapenem-Resistant Gram-Negative Bacterial Infections in Children

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2020; 64(3): Nº de citas: 64 [doi:10.1128/AAC.02183-19]

Sanz, JC; Rodriguez-Avial, I; Rios, E; Garcia-Comas, L; Ordobas, M; Cercenado, E.

Increase of serotype 8, ST53 clone, as the prevalent strain of Streptococcus pneumoniae causing invasive disease in Madrid, Spain (2012-2015)

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2020; 38(3): 105-110 Nº de citas: 15 [doi:10.1016/j.eimc.2019.05.006]

Reigadas, E; Vazquez-Cuesta, S; Onori, R; Villar-Gomara, L; Alcala, L; Marin, M; Martin, A; Muñoz P; Bouza, E.

Clostridioides difficile contamination in a clinical microbiology laboratory?

CLINICAL MICROBIOLOGY AND INFECTION. 2020; 26(3): 340-344 Nº de citas: 7 [doi:10.1016/j.cmi.2019.06.027]

Abascal, E; Herranz, M; Acosta, F; Agapito, J; Cabibbe, AM; Monteserin, J; Serrano, MJR; Gijon, P; Fernandez-Gonzalez, F; Lozano, N; Chiner-Oms, A; Caceres, T; Pintado, PG; Acin, E; Valencia, E; Munoz, P; Comas, I; Cirillo, DM; Ritacco, V; Gotuzzo, E; de Viedma, DG.

Screening of inmates transferred to Spain reveals a Peruvian prison as a reservoir of persistent Mycobacterium tuberculosis MDR strains and mixed infections

Scientific Reports. 2020; 10(1): Nº de citas: 18 [doi:10.1038/s41598-020-59373-w]

Pericas, JM; Llopis, J; Munoz, P; Galvez-Acebal, J; Kestler, M; Valerio, M; Hernandez-Meneses, M; Goenaga, MA; Cobo-Belaustegui, M; Montejo, M; Ojeda-Burgos, G; Sousa-Regueiro, MD; de Alarcon, A; Ramos-Martinez, A; Miro, JM; GAMES Investigators.

A Contemporary Picture of Enterococcal Endocarditis

JACC-Journal of the American College of Cardiology. 2020; 75(5): 482-494 Nº de citas: 94 [doi:10.1016/j.jacc.2019.11.047]

Cornely, OA; Mullane, KM; Birch, T; Hazan-Steinberg, S; Nathan, R; Bouza, E; Calfee, DP; Ellison, MC; Wong, MT; Dorr, MB.

Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer

Open Forum Infectious Diseases. 2020; 7(2): Nº de citas: 11 [doi:10.1093/ofid/ofaa038]

Reigadas, E; Alcala, L; Marin, M; Martin, A; Munoz, P; Bouza, E; Spanish C Difficile Toxin Cycle St.

Prediction of poor outcome in Clostridioides difficile infection: A multicentre external validation of the toxin B amplification cycle

ANAEROBE. 2020; 61: Nº de citas: 6 [doi:10.1016/j.anaerobe.2019.102079]

Bouza, E; Alvar, A; Almagro, P; Alonso, T; Ancochea, J; Barbe, F; Corbella, J; Gracia, D; Mascaros, E; Melis, J; Miravitlles, M; Pastor, M; Perez, P; Rudilla, D; Torres, A; Soriano, JB; Vallano, A; Vargas, F; Palomo, E.

Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document

Revista Espanola de Quimioterapia. 2020; 33(1): 49-67 Nº de citas: 20 [doi:10.37201/req/2064.2019]

Larrosa, MN; Benito, N; Canton, R; Canut, A; Cercenado, E; Fernandez-Cuenca, F; Guinea, J; Lopez-Navas, A; Moreno, MA; Oliver, A; Martinez-Martinez, L.

From CLSI to EUCAST, a necessary step in Spanish laboratories

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2020; 38(2): 79-83 Nº de citas: 11 [doi:10.1016/j.eimc.2018.09.014]

Bouza, E; Almirante, B; Rodriguez, JG; Garnacho-Montero, J; Salavert, M; Munoz, P; Sanguinetti, M.

Biomarkers of fungal infection: Expert opinion on the current situation

Revista Espanola de Quimioterapia. 2020; 33(1): 1-10 Nº de citas: 29 [doi:10.37201/req/2260.2019]

Perez-Granda, MJ; Bouza, E; Pinilla, B; Cruces, R; Gonzalez, A; Millan, J; Guembe, M.

Randomized clinical trial analyzing maintenance of peripheral venous catheters in an internal medicine unit: Heparin vs. saline

PLoS One. 2020; 15(1): Nº de citas: 15 [doi:10.1371/journal.pone.0226251]

Aguilera, A; Alados, JC; Alonso, R; Eiros, JM; Garcia, F.

Current position of viral load versus hepatitis C core antigen testing

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2020; 38: 12-18 Nº de citas: 8

Marcos-Zambrano, LJ; Bordallo-Cardona, MA; Borghi, E; Falleni, M; Tosi, D; Muñoz P; Escribano, P; Guinea, J.

Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella

MEDICAL MYCOLOGY. 2020; 58(1): 83-92 Nº de citas: 23 [doi:10.1093/mmy/myz027]

Ercibengoa, M; Camara, J; Tubau, F; Garcia-Somoza, D; Galar, A; Martin-Rabadan, P; Marin, M; Mateu, L; Garcia-Olive, I; Prat, C; Cilloniz, C; Torres, A; Pedro-Botet, ML; Ardanuy, C; Munoz, P; Marimon, JM.

A multicentre analysis of Nocardia pneumonia in Spain: 2010-2016

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2020; 90: 161-166 Nº de citas: 46 [doi:10.1016/j.ijid.2019.10.032]

Garcia-Broncano, P; Medrano, LM; Berenguer, J; Brochado-Kith, O; Gonzalez-Garcia, J; Jimenez-Sousa, A; Quereda, C; Sanz, J; Tellez, MJ; Diaz, L; JImenez, JL; Resino, S; Carrero, A; Miralles, P; Lopez, JC; Parras, F; Padilla, B; Aldamiz-Echevarria, T; Tejerina, F; Diez, C; Perez-Latorre, L; Fanciulli, C; Gutierrez, I; Ramirez, M; Carretero, S; Bellon, JM; Bermejo, J; Berenguer, J; Hontanon, V; Arribas, JR; Montes, ML; Bernardino, I; Pascual, JF; Zamora, F; Pena, JM; Arnalich, F; Diaz, M; Gonzalez-Garcia, J; Domingo, P; Guardiola, JM; Van den Eynde, E; Perez, M; Ribera, E; Crespo, M; Casado, JL; Dronda, F; Moreno, A; Perez-Elias, MJ; Sanfrutos, MA; Moreno, S; Quereda, C; Arranz, A; Casas, E; de Miguel, J; Schroeder, S; Sanz, J; Santos, I; Bustinduy, MJ; Iribarren, JA; Rodriguez-Arrondo, F; Von-Wichmann, MA; Vergas, J; Tellez, MJ; Vinuesa, D; Munoz, L; Hernandez-Quero, J; Ferrer, A; Galindo, MJ; Ortiz, L; Ortega, E; Montero, M; Blanes, M; Cuellar, S; Lacniz, J; Salavert, M; Lopez-Aldeguer, J; Perez, G; Gaspar, G; Yllescas, M; Crespo, P; Aznar, E; Esteban, H; GESIDA 3603b Study Grp.

Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study

JOURNAL OF INFECTION. 2020; 80(1): 99-110 Nº de citas: 13 [doi:10.1016/j.jinf.2019.09.020]

Cornely, OA; Alastruey-Izquierdo, A; Arenz, D; Chen, SCA; Dannaoui, E; Hochhegger, B; Hoenigl, M; Jensen, HE; Lagrou, K; Lewis, RE; Mellinghoff, SC; Mer, M; Pana, ZD; Seidel, D; Sheppard, DC; Wahba, R; Akova, M; Alanio, A; Al-Hatmi, AMS; Arikan-Akdagli, S; Badali, H; Ben-Ami, R; Bonifaz, A; Bretagne, S; Castagnola, E; Chayakulkeeree, M; Colombo, AL; Corzo-Leon, DE; Drgona, L; Groll, AH; Guinea, J; Heussel, CP; Ibrahim, AS; Kanj, SS; Klimko, N; Lackner, M; Lamoth, F; Lanternier, F; Lass-Floerl, C; Lee, DG; Lehrnbecher, T; Lmimouni, BE; Mares, M; Maschmeyer, G; Meis, JF; Meletiadis, J; Morrissey, CO; Nucci, M; Oladele, R; Pagano, L; Pasqualotto, A; Patel, A; Racil, Z; Richardson, M; Roilides, E; Ruhnke, M; Seyedmousavi, S; Sidharthan, N; Singh, N; Sinko, J; Skiada, A; Slavin, M; Soman, R; Spellberg, B; Steinbach, W; Tan, BH; Ullmann, AJ; Vehreschild, JJ; Vehreschild, MJGT; Walsh, TJ; White, PL; Wiederhold, NP; Zaoutis, T; Chakrabarti, A; Mucormycosis ECMM MSG Global.

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

LANCET INFECTIOUS DISEASES. 2019; 19(12): 405-421 Nº de citas: 1634 [doi:10.1016/S1473-3099(19)30312-3]